ORAMED PHARMACEUTICL | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (35)

View All

Latest Posts

About This Stock More About This Stock
Week In Review: Mundipharma Considers $1 Billion Sale Of China Operations
Article By: ChinaBio® Today
Saturday, August 5, 2023 2:19 PM EDT
Mundipharma is considering selling its China operations in a deal that could be worth $1 billion. Additionally, Oramed Pharma plans to form a $60 million JV with Hefei Tianhui Biotech to commercialize Oramed's oral drug delivery products globally.
In this article: ABVC, AZN, PFE, ORMP, CASI, LIAN
Read
Wall Street Divided After Key Inflation Reading
Article By: Schaeffers Research
Thursday, January 12, 2023 12:26 PM EDT
Stocks are a mixed bag midday, despite this morning's encouraging consumer price index (CPI).
In this article: VOD, ORMP, QQQ, SPX, VIX, DJI, BBAI
Read
Stock Charts To Watch - Thursday, December 19
Video By: Harry Boxer
Thursday, December 19, 2019 10:00 PM EDT
Endo International plc swing trade is acting well and looks to me like it wants to get going.
In this video: IMGN, ENDP, ORMP, INMD, RAD
Watch
Stock Charts To Watch - Wednesday, Dec. 18
Video By: Harry Boxer
Wednesday, December 18, 2019 11:18 PM EDT
Axsome Therapeutics, Inc. jumped 8.60, or 11%, to 89.57, just pennies off its high at 89.65, on 2.4 million shares on Wednesday.
In this video: BBBY, AXSM, ORMP, IMGN, SCOR, WRTC
Watch
Week In Review: CanSino Nears $1 Billion Valuation Following Hong Kong IPO
Article By: ChinaBio® Today
Saturday, March 30, 2019 4:05 PM EDT
CanSino Biologics, a Tianjin vaccine company, rose 58% in its first trading day on the Hong Kong Exchange after staging its $161 million IPO. At the IPO price, CanSino was valued at $617 million; its market capitalization is now $968 million.
In this article: AZN, MDT, ORMP
Read
All Posts

Latest Tweets for $ORMP

No tweets yet!

PARTNER HEADLINES

$ORMP

Comments Status Updates
Here's My Top Value Stock To Buy Right Now
Mike Faragut • 11/1/2021 1:38:52 PM

$ORMP is has interesting value. They've just announced that they're starting Phase I trials for their oral covid vaccine. Keep an eye on it today,

1 to 1 of 1 comments